Achieving the world health organization’s vision for clinical pharmacology

Jennifer H. Martin, David Henry, Jean Gray, Richard Day, Felix Bochner, Albert Ferro, Munir Pirmohamed, Klaus Mörike, Matthias Schwab

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

Clinical pharmacology is a medical specialty whose practitioners teach, undertake research, frame policy, give information and advice about the actions and proper uses of medicines in humans and implement that knowledge in clinical practice. It involves a combination of several activities: drug discovery and development, training safe prescribers, providing objective and evidence-based therapeutic information to ethics, regulatory and pricing bodies, supporting patient care in an increasingly subspecialized arena where co-morbidities, polypharmacy, altered pharmacokinetics and drug interactions are common and developing and contributing to medicines policies for Governments. Clinical pharmacologists must advocate drug quality and they must also advocate for sustainability of the Discipline. However for this they need appropriate clinical service and training support. This Commentary discusses strategies to ensure the Discipline is supported by teaching, training and policy organizations, to communicate the full benefits of clinical pharmacology services, put amonetary value on clinical pharmacology services and to grow the clinical pharmacology workforce to support a growing clinical, academic and regulatory need.

Original languageEnglish
Pages (from-to)223-227
Number of pages5
JournalBritish Journal of Clinical Pharmacology
Volume81
Issue number2
Early online date14 Oct 2015
DOIs
Publication statusPublished - 8 Feb 2016
Externally publishedYes

Fingerprint

Clinical Pharmacology
Polypharmacy
Training Support
Drug Discovery
Drug Interactions
Ethics
Patient Care
Teaching
Pharmacokinetics
Medicine
Organizations
Morbidity
Costs and Cost Analysis
Research
Pharmaceutical Preparations
Therapeutics

Cite this

Martin, Jennifer H. ; Henry, David ; Gray, Jean ; Day, Richard ; Bochner, Felix ; Ferro, Albert ; Pirmohamed, Munir ; Mörike, Klaus ; Schwab, Matthias. / Achieving the world health organization’s vision for clinical pharmacology. In: British Journal of Clinical Pharmacology. 2016 ; Vol. 81, No. 2. pp. 223-227.
@article{b84de7d6e49b43aab20da14d372a8070,
title = "Achieving the world health organization’s vision for clinical pharmacology",
abstract = "Clinical pharmacology is a medical specialty whose practitioners teach, undertake research, frame policy, give information and advice about the actions and proper uses of medicines in humans and implement that knowledge in clinical practice. It involves a combination of several activities: drug discovery and development, training safe prescribers, providing objective and evidence-based therapeutic information to ethics, regulatory and pricing bodies, supporting patient care in an increasingly subspecialized arena where co-morbidities, polypharmacy, altered pharmacokinetics and drug interactions are common and developing and contributing to medicines policies for Governments. Clinical pharmacologists must advocate drug quality and they must also advocate for sustainability of the Discipline. However for this they need appropriate clinical service and training support. This Commentary discusses strategies to ensure the Discipline is supported by teaching, training and policy organizations, to communicate the full benefits of clinical pharmacology services, put amonetary value on clinical pharmacology services and to grow the clinical pharmacology workforce to support a growing clinical, academic and regulatory need.",
author = "Martin, {Jennifer H.} and David Henry and Jean Gray and Richard Day and Felix Bochner and Albert Ferro and Munir Pirmohamed and Klaus M{\"o}rike and Matthias Schwab",
year = "2016",
month = "2",
day = "8",
doi = "10.1111/bcp.12803",
language = "English",
volume = "81",
pages = "223--227",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "BLACKWELL SCIENCE LTD",
number = "2",

}

Martin, JH, Henry, D, Gray, J, Day, R, Bochner, F, Ferro, A, Pirmohamed, M, Mörike, K & Schwab, M 2016, 'Achieving the world health organization’s vision for clinical pharmacology' British Journal of Clinical Pharmacology, vol. 81, no. 2, pp. 223-227. https://doi.org/10.1111/bcp.12803

Achieving the world health organization’s vision for clinical pharmacology. / Martin, Jennifer H.; Henry, David; Gray, Jean; Day, Richard; Bochner, Felix; Ferro, Albert; Pirmohamed, Munir; Mörike, Klaus; Schwab, Matthias.

In: British Journal of Clinical Pharmacology, Vol. 81, No. 2, 08.02.2016, p. 223-227.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Achieving the world health organization’s vision for clinical pharmacology

AU - Martin, Jennifer H.

AU - Henry, David

AU - Gray, Jean

AU - Day, Richard

AU - Bochner, Felix

AU - Ferro, Albert

AU - Pirmohamed, Munir

AU - Mörike, Klaus

AU - Schwab, Matthias

PY - 2016/2/8

Y1 - 2016/2/8

N2 - Clinical pharmacology is a medical specialty whose practitioners teach, undertake research, frame policy, give information and advice about the actions and proper uses of medicines in humans and implement that knowledge in clinical practice. It involves a combination of several activities: drug discovery and development, training safe prescribers, providing objective and evidence-based therapeutic information to ethics, regulatory and pricing bodies, supporting patient care in an increasingly subspecialized arena where co-morbidities, polypharmacy, altered pharmacokinetics and drug interactions are common and developing and contributing to medicines policies for Governments. Clinical pharmacologists must advocate drug quality and they must also advocate for sustainability of the Discipline. However for this they need appropriate clinical service and training support. This Commentary discusses strategies to ensure the Discipline is supported by teaching, training and policy organizations, to communicate the full benefits of clinical pharmacology services, put amonetary value on clinical pharmacology services and to grow the clinical pharmacology workforce to support a growing clinical, academic and regulatory need.

AB - Clinical pharmacology is a medical specialty whose practitioners teach, undertake research, frame policy, give information and advice about the actions and proper uses of medicines in humans and implement that knowledge in clinical practice. It involves a combination of several activities: drug discovery and development, training safe prescribers, providing objective and evidence-based therapeutic information to ethics, regulatory and pricing bodies, supporting patient care in an increasingly subspecialized arena where co-morbidities, polypharmacy, altered pharmacokinetics and drug interactions are common and developing and contributing to medicines policies for Governments. Clinical pharmacologists must advocate drug quality and they must also advocate for sustainability of the Discipline. However for this they need appropriate clinical service and training support. This Commentary discusses strategies to ensure the Discipline is supported by teaching, training and policy organizations, to communicate the full benefits of clinical pharmacology services, put amonetary value on clinical pharmacology services and to grow the clinical pharmacology workforce to support a growing clinical, academic and regulatory need.

UR - http://www.scopus.com/inward/record.url?scp=85003483422&partnerID=8YFLogxK

U2 - 10.1111/bcp.12803

DO - 10.1111/bcp.12803

M3 - Article

VL - 81

SP - 223

EP - 227

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 2

ER -